This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07981/identifier/chemspider/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://linked.opendata.cz/resource/drugbank/drug/DB07981/identifier/pdb/
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07981/identifier/pubchem-compound/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07981/identifier/pubchem-substance/
n4http://linked.opendata.cz/resource/drugbank/drug/DB07981/identifier/drugbank/

Statements

Subject Item
n2:DB07981
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n9:DB07981 n10:DB07981
dcterms:title
2-[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YL]-N-[(1R)-1-(HYDROXYMETHYL)PROPYL]ACETAMIDE
adms:identifier
n4:DB07981 n11:IM8 n12:99444452 n13:16741227 n14:20572534
n5:IUPAC-Name
n6:271B525E-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B5264-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B5263-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5260-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5261-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5262-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B525C-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B525A-363D-11E5-9242-09173F13E4C5 n6:271B525D-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B525B-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B526A-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B526B-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5265-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5266-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5268-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5267-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5269-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5270-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5272-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5273-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B526F-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B526E-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5271-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B525F-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B526C-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B526D-363D-11E5-9242-09173F13E4C5